US5458130A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Ultrasonic therapy and assessment apparatus and method
Assignee: DJO LLC
•
Filing: 1993-11-08
•
Granted: 1995-10-17
•
Expires: 2013-11-08
Abstract
Abstract Non-invasive therapeutic treatment and/or quantitative evaluation of musculoskeletal tissue are performed in vivo by subjecting musculoskeletal tissue to an ultrasonic acoustic signal pulse of finite duration, and involving a composite sine-wave signal consisting of plural discrete frequencies that are spaced in the ultrasonic region to approximately 2 MHZ; the excitation signal is repeated substantially in the range 1 to 1000 Hz. In a quantitative evaluation, the composite-sine wave signal is supplied to one of two transducers on opposite sides of the musculoskeletal tissue, and the signal received by the other transducer is processed (a) to sequentially average the most recently received given number of successive signals to obtain an averaged per-pulse signal and (b) to produce a Fourier transform of the averaged per-pulse musculoskeletal tissue-transmitted signal. In a separate operation not involving the musculoskeletal tissue, the same transducers are subjected to the same excitation, reception and processing, wherein the transducers are exposed to a medium of known acoustic properties and path length, all to the end of producing a reference Fourier transform which is processed with the Fourier transform of the musculoskeletal tissue-transmitted signal, to yield an evaluation or measurement. In a therapeutic treatment, the transducer excited by the composite sine-wave signal is thus applied for a period or periods of time, and with a magnitude, as may be prescribed by the physician for a given patient.
Inventors
- 👤 Jonathan J. Kaufman
- 👤 Alessandro E. Chiabrera
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-10 02:24
CPC Classifications
G; G01; G01N; G01N29/00; G01N29/34; G01N29/348; A; A61; A61B; A61B8/00; A61B8/08; A61B8/0875; A61N; A61N7/00; G01N29/22; G01N29/30; G01N29/44; G01N29/449; G01N2291/00; G01N2291/02; G01N2291/024; G01N2291/02483; Y; Y10; Y10S; Y10S128/00; Y10S128/92; Y10S128/925
Claims Analysis
Total Claims: 10
Claim 1
Independent Claim
193 words
Apparatus for non-invasive therapeutic treatment to and/or quantitative evaluation of musculoskeletal tissue in vivo, comprising an (a) ultrasonic transducer that is non-invasively adapted for acoustic coupling to nearby skin and for transmission through a musculoskeletal part of a living body; (b) and means for driving said transducer with a finite-duration composite sine-wave excitation signal meeting the requirements of the following relationship: ##EQU10## where a i and φ i are the amplitude and phase, respectively, associated with frequency f i , i=1, . . . , N, and T is chosen to be at least two times longer than the period of the lowest frequency f i ; where said composite sine-wave signal consists of plural discrete frequencies that are spaced in the ultrasonic spectral region to approximately 2 MHz and repeating said excitation signal at a rate in the range 1 to 1000 Hz; and where the amplitudes a i are chosen according to the relationship: ##EQU11## wherein B is the attenuation of an average musculoskeletal member and |H t (f i )| is the magnitude transfer function of said ultrasonic transducer, thereby producing a musculoskeletal tissue-transmitted acoustic signal for musculoskeletal tissue therapy.
Claim 2
Dependent Claim
193 words
Apparatus for non-invasive therapeutic treatment to and/or quantitative evaluation of musculoskeletal tissue in vivo, comprising an (a) ultrasonic transducer that is non-invasively adapted for acoustic coupling to nearby skin and for transmission through a musculoskeletal part of a living body; (b) and means for driving said transducer with a finite-duration composite sine-wave excitation signal meeting the requirements of the following relationship: ##EQU10## where a i and φ i are the amplitude and phase, respectively, associated with frequency f i , i=1, . . . , N, and T is chosen to be at least two times longer than the period of the lowest frequency f i ; where said composite sine-wave signal consists of plural discrete frequencies that are spaced in the ultrasonic spectral region to approximately 2 MHz and repeating said excitation signal at a rate in the range 1 to 1000 Hz; and where the amplitudes a i are chosen according to the relationship: ##EQU11## wherein B is the attenuation of an average musculoskeletal member and |H t (f i )| is the magnitude transfer function of said ultrasonic transducer, thereby producing a musculoskeletal tissue-transmitted acoustic signal for musculoskeletal tissue therapy.
Claim 3
Dependent Claim
126 words
Apparatus according to claim 1, further including (c) a second ultrasonic transducer non-invasively adapted for acoustic response to said tissue-transmitted signal, thereby producing an electrical output signal; (d) means for sequentially processing each electrical-output signal by averaging a succession of said electrical-output signals to obtain an averaged per-pulse signal, each averaging being over a predetermined minimum period of time exceeding substantially one millisecond; (e) selectively operable means including a medium of known acoustic properties and path length and adapted to use said transducers and said excitation signal via said medium independently of coupling to the living body, whereby to establish a reference signal; (f) means for separately storing the reference signal; and (g) means for comparatively evaluating the averaged per-pulse signal against the stored reference signal.
Claim 4
Independent Claim
206 words
The method of non-invasively therapeutically treating musculoskeletal tissue in vivo, using an ultrasonic transducer that is non-invasively adapted for acoustic coupling to nearby skin and for transmission through a musculoskeletal part of a living body, which method comprises the steps of: (a) acoustically coupling said transducer to nearby skin in a direction toward said musculoskeletal part; (b) driving said transducer with a finite-duration composite sine-wave excitation signal meeting the requirements of the following relationship: ##EQU12## where a i and φ i are the amplitude and phase, respectively, associated with frequency f i , i=1, . . . , N, and T is chosen to be at least two times longer than the period of the lowest frequency f i ; where said composite sine-wave signal consists of plural discrete frequencies that are spaced in the ultrasonic spectral region to approximately 2 MHz and repeating said excitation signal at a rate in the range 1 to 1000 Hz; and where the amplitudes a i are chosen according to the relationship: ##EQU13## wherein B is the attenuation of an average musculoskeletal member and |H t (f i )| is the magnitude transfer function of said ultrasonic transducer, thereby producing a musculoskeletal tissue-transmitted acoustic signal for musculoskeletal tissue therapy.
Claim 5
Independent Claim
206 words
The method of non-invasively therapeutically treating musculoskeletal tissue in vivo, using an ultrasonic transducer that is non-invasively adapted for acoustic coupling to nearby skin and for transmission through a musculoskeletal part of a living body, which method comprises the steps of: (a) acoustically coupling said transducer to nearby skin in a direction toward said musculoskeletal part; (b) driving said transducer with a finite-duration composite sine-wave excitation signal meeting the requirements of the following relationship: ##EQU12## where a i and φ i are the amplitude and phase, respectively, associated with frequency f i , i=1, . . . , N, and T is chosen to be at least two times longer than the period of the lowest frequency f i ; where said composite sine-wave signal consists of plural discrete frequencies that are spaced in the ultrasonic spectral region to approximately 2 MHz and repeating said excitation signal at a rate in the range 1 to 1000 Hz; and where the amplitudes a i are chosen according to the relationship: ##EQU13## wherein B is the attenuation of an average musculoskeletal member and |H t (f i )| is the magnitude transfer function of said ultrasonic transducer, thereby producing a musculoskeletal tissue-transmitted acoustic signal for musculoskeletal tissue therapy.
Claim 6
Dependent Claim
149 words
The method of claim 3, wherein status of the musculoskeletal-tissue is evaluated concurrently with the therapeutic treatment and said transducer is one of two transducers coupled to nearby skin on opposite sides of said musculoskeletal tissue part, the other of said transducers being adapted for receiving signals that have propagated through said musculoskeletal tissue part, said method including the further steps of: (c) sequentially processing each electrical-output signal by averaging a succession of signals to obtain an averaged per-pulse signal, each averaging being over a predetermined minimum period of time exceeding substantially one millisecond; (d) selectively using said transducers and said excitation signal via a medium of known acoustic properties and path length, said selective use being independent of coupling to the living body, whereby to establish a reference signal; (e) separately storing the reference signal; and (f) comparatively evaluating the averaged per-pulse signal against the stored reference signal.
Claim 7
Dependent Claim
13 words
The method of claim 3, wherein the musculoskeletal tissue being treated is bone.
Claim 8
Dependent Claim
13 words
The method of claim 3, wherein the musculoskeletal tissue being treated is cartilage.
Claim 9
Dependent Claim
13 words
The method of claim 3, wherein the musculoskeletal tissue being treated is ligament.
Claim 10
Dependent Claim
13 words
The method of claim 3, wherein the musculoskeletal tissue being treated is tendon.
References Cited (Backward Citations)
US3847141A
Cited
US4361154A
Cited
US4421119A
Cited
US4530360A
Cited
US4774959A
Cited
US4913157A
Cited
US5054490A
Cited
US4941474A
Cited
US4926870A
Cited
US5259384A
Cited
US5309898A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1998-10-16 | 1999-04-17 | 1999-10-17 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2002-10-16 | 2003-04-17 | 2003-10-17 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2006-10-16 | 2007-04-17 | 2007-10-17 | $7700.00 | Window Closed / Lapsed |